Is this U.S.-China selloff a buy? A top Wall Street voice weighs in
Bausch Health Companies Inc. (NYSE:BHC, TSX:BHC) announced that its shareholders approved the ratification, confirmation, and adoption of its Amended and Restated Shareholder Rights Plan Agreement at a special meeting held Tuesday. According to a statement in the company’s SEC filing, the resolution received 178,244,775 votes in favor and 40,130,633 votes against.
The Rights Plan Agreement was originally dated April 14, 2025, and was amended and restated on August 25, 2025. Details of the agreement were provided to shareholders in the company’s Management Proxy Circular and Proxy Statement dated August 27, 2025.
The approval was the sole proposal presented at the special meeting. Bausch Health Companies Inc. is incorporated in British Columbia, Canada, and its common shares are listed on both the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol BHC.
This information is based on a company statement included in a recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.